<DOC>
	<DOC>NCT00142974</DOC>
	<brief_summary>This study is being done to evaluate the safety, tolerability and satisfactory relief of tegaserod against dyspeptic symptoms in diabetic patients with symptoms of diabetic gastropathy.</brief_summary>
	<brief_title>Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy</brief_title>
	<detailed_description />
	<mesh_term>Stomach Diseases</mesh_term>
	<mesh_term>Tegaserod</mesh_term>
	<criteria>History of Type 1 or insulinrequiring Type 2 diabetes for at least 3 years GI symptoms for at least 2 months before entering study Very high body weight Significant diarrhea Ulcers Symptom severity score collected via diary Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Diabetes, tegaserod, gastropathy</keyword>
</DOC>